» Articles » PMID: 24748184

MicroRNA-194 Inhibits the Epithelial-mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2014 Apr 22
PMID 24748184
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: We hypothesized that miR-194 may control Forkhead box protein M1 (FoxM1) expression in gastric cancer cells and therefore may have therapeutic potential in gastric cancer.

Methods: The expression level of miR-194 was examined using real-time PCR in human gastric cancer and noncancerous gastric tissues, gastric cancer cell and normal gastric mucosal epithelial cell. We examined whether the miR-194 regulates cell migration and invasion, and the epithelial-mesenchymal transition Phenotype by inhibiting FoxM1 in gastric cancer cells.

Results: The expression of miR-194 was significantly lower in gastric cancer compared with non-cancerous gastric tissues and cells. Exogenous expression of miR-194 inhibited cell migration, invasion, and the epithelial-mesenchymal transition phenotype in gastric cancer cells. Moreover, we discovered a novel post-transcriptional regulatory mechanism of FoxM1 expression that is mediated by miR-194.

Conclusion: Our study clearly demonstrates that miR-194 inhibits the acquisition of the EMT phenotype in gastric cancer cells by downregulating FoxM1, thereby inhibiting cell migration and invasion during cancer progression.

Citing Articles

Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells.

Yen Y, Yang J, Chang J, Tsai S Int J Mol Sci. 2022; 23(1).

PMID: 35008751 PMC: 8745262. DOI: 10.3390/ijms23010325.


KLF5 activates lncRNA DANCR and inhibits cancer cell autophagy accelerating gastric cancer progression.

Cheng Z, Liu G, Huang C, Zhao X NPJ Genom Med. 2021; 6(1):75.

PMID: 34548487 PMC: 8455684. DOI: 10.1038/s41525-021-00207-7.


MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1.

Xia M, Sheng L, Qu W, Xue X, Chen H, Zheng G World J Surg Oncol. 2021; 19(1):174.

PMID: 34127010 PMC: 8204537. DOI: 10.1186/s12957-021-02278-3.


Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients.

Wang T, Li W, Li H, Li W Saudi J Biol Sci. 2021; 28(3):1561-1568.

PMID: 33732041 PMC: 7938118. DOI: 10.1016/j.sjbs.2021.01.013.


miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.

Wang J, Zhang M, Hu X, She J, Sun R, Qin S FEBS Open Bio. 2021; 11(7):1814-1826.

PMID: 33605558 PMC: 8255842. DOI: 10.1002/2211-5463.13125.


References
1.
Laoukili J, Stahl M, Medema R . FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta. 2006; 1775(1):92-102. DOI: 10.1016/j.bbcan.2006.08.006. View

2.
Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A . Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem. 2011; 112(9):2296-306. PMC: 3155646. DOI: 10.1002/jcb.23150. View

3.
Zheng L, Wang L, Ajani J, Xie K . Molecular basis of gastric cancer development and progression. Gastric Cancer. 2004; 7(2):61-77. DOI: 10.1007/s10120-004-0277-4. View

4.
Llaurado M, Majem B, Castellvi J, Cabrera S, Gil-Moreno A, Reventos J . Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer. Mol Cancer Res. 2012; 10(7):914-24. DOI: 10.1158/1541-7786.MCR-11-0449. View

5.
Sundaram P, Hultine S, Smith L, Dews M, Fox J, Biyashev D . p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res. 2011; 71(24):7490-501. PMC: 3242824. DOI: 10.1158/0008-5472.CAN-11-1124. View